Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 64-66, January 2009

Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)

  • Stacy Loeb, M.D.

      Affiliations

    • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
  • ,
  • Sara N. Gashti, B.S.

      Affiliations

    • Department of Urology, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA
  • ,
  • William J. Catalona, M.D.

      Affiliations

    • Department of Urology, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA
    • Corresponding Author InformationCorresponding author. Tel.: 312-695-4471; fax: 312-695-1482

Abstract 

Prostate inflammation can lead to an elevation in the serum PSA concentration and confound the use of PSA kinetics. This can have considerable clinical consequences, since these measurements form the basis for important clinical decisions. Thus, there has been investigation into ways to decrease the confounding from inflammation, including repeat PSA measurements after a period of observation or a course of empiric antibiotics. This article reviews the evidence about elevations in PSA due to prostatitis and describes the controversy over the optimal approach to reduce its confounding impact on prostate cancer screening.

Keywords: Prostate cancer, PSA, Antibiotics, Prostatitis, Prostate biopsy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1078-1439(08)00076-8

doi:10.1016/j.urolonc.2008.04.002

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 64-66, January 2009